Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Ongoing drug recalls - open right now

Every FDA drug recall whose status is still Ongoing: the firm is still removing product from the market, or the FDA has not yet closed the file. Some were opened years ago and never formally terminated, so check the initiation date as well as the status.

2,760 recalls, newest first.

Class II · Moderate risk

Zicam

CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing

Ongoing Microbial contamination Church & Dwight Co., Inc. D-0790-2026
Class II · Moderate risk

Carbamazepine Tablets

CGMP deviations: tablets with black specks.

Ongoing cGMP deviation Golden State Medical Supply Inc. NDC 51407-215-10 D-0771-2026
Class II · Moderate risk

Daptomycin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-0718-12 D-0821-2026
Class II · Moderate risk

Vasopressin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-9647-12 D-0819-2026
Class II · Moderate risk

Cardene IV

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 43066-016-10 D-0813-2026
Class II · Moderate risk

Vasopressin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-9640-12 D-0811-2026
Class II · Moderate risk

Daptomycin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-0714-24 D-0807-2026
Class II · Moderate risk

Myxredlin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-0126-12 D-0806-2026
Class II · Moderate risk

Acthar Gel

Presence of particulate matter: glass and stopper piece

Ongoing Particulate / foreign matter Mallinckrodt Hospital Products Inc. NDC 63004-8710-1 D-0803-2026

Recalls by year